Yüklüyor......
Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
BACKGROUND: Suppressive immune cells present in tumour microenvironments are known to augment tumour growth and hamper efficacy of antitumour therapies. The amino-bisphosphonate Zoledronic acid (ZA) is considered as an antitumour agent, as recent studies showed that ZA prolongs disease-free survival...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2938257/ https://ncbi.nlm.nih.gov/pubmed/20664588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605814 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|